SELLAS Life Sciences prices $150 million stock offering at $13 per share
SELLAS Life Sciences signed a placement agreement with J.P. Morgan Securities and TD Securities for a public offering of 11,538,462 common shares at $13 per share. The placement agents also received a 30-day option to buy up to 1,730,769 additional shares; if fully exercised, the company expects net proceeds of about $161.8 million after deducting discounts, commissions and estimated expenses. The offering is expected to close on or around November 20, 2026.









